Chemotherapy and cure: the current opportunities for patients
For several decades, chemotherapy was based on protocols, i.e. rigid combinations of medicines to be used for all patients. A new era began with the introduction of immunochemotherapy, though the last 15 years saw the rising of personalized therapies thanks to tumour genotyping. This approach is commonly known as Precision Medicine and has the advantage of a rapid translation from laboratory experiment results to patients. The current and future frontier is represented by cell therapies, including the use of patient cells as real medicines or “living drugs”.